- Supported exchanges /
- F /
- CT9.F
CARDIOL THERAPEUTICS CL.A (CT9 F) stock market data APIs
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
CARDIOL THERAPEUTICS CL.A Financial Data Overview
| 1.632 | |
| 1.632 | |
| - | |
| 1.632 | |
| 1.632 | |
| 0.695-2.8 | |
| 135 M | |
| 79 585 K | |
| 0 | |
| 0.697 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
CARDIOL THERAPEUTICS CL.A Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -31 661 444
- Earnings Per Share -0.29
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get CARDIOL THERAPEUTICS CL.A Earnings via APIs
- Latest Release NaN
- EPS/Forecast NaN
Get CARDIOL THERAPEUTICS CL.A End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
